Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2021
Source ID
10.1016/j.xcrm.2021.100267

Entities

People

  • Ahna Van Gaest
  • Anna Ritz
  • Changhui Xue
  • Christopher W. Ryan
  • Daniel S. Derrick
  • Devin Garg
  • George V Thomas
  • Hui-wen Lue
  • Jennifer Podolak
  • Justin M Drake
  • Larry C Cheng
  • Laura M Heiser
  • Ralph White Iii
  • Samantha Lawson
  • Soumya Rao

Organizations

  • National Cancer Institute
  • Prostate Cancer Foundation
  • United States Department of Defense